Canreal 50mg (Cangrelor Vials) 50mg

Canreal 50mg (Cangrelor) is an antiplatelet injection used to reduce blood clot risks during medical procedures. This 50mg vial form helps prevent complications in patients undergoing stent placement or heart interventions. A fast-acting platelet inhibitor designed for short-term use in clinical settings.

Strength

50mg

Manufacturer / TM Owner

MSN Laboratories Pvt Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Cangrelor 50mg is primarily used to prevent blood clots in patients undergoing percutaneous coronary intervention (PCI) or stent placement. It works by inhibiting platelet aggregation, reducing the risk of clot-related complications during procedures. This medication is often administered in hospital settings where rapid antiplatelet action is required.

Side Effects

After administration, Cangrelor 50mg begins working within minutes to reduce platelet activity. Patients may experience a decrease in clot formation risk, which can help prevent blockages in blood vessels. The effects are temporary and typically wear off shortly after the infusion stops.

Precautions & Warnings

Cangrelor 50mg should be handled with care by healthcare professionals in a clinical environment. Patients with active bleeding or a history of bleeding disorders may need special monitoring. Always inform your doctor about current medications or medical conditions before receiving this injection.

Avoid Interactions

Cangrelor may interact with other blood thinners or medications that affect platelet function. Combining it with certain drugs could increase bleeding risks. Alcohol and herbal supplements may also influence its effects, so consult a healthcare provider before use.

References

Frequently Asked Questions

Canreal 50mg is used to prevent blood clots during medical procedures like stent placement.

It is given as an intravenous injection in a hospital setting by healthcare professionals.

No, this medication is only administered in a clinical environment under medical supervision.

Common effects may include bleeding or bruising at the injection site.

It should be used with caution in patients with bleeding disorders or active bleeding.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.